PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.43%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
-0.51%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
51.44%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
1.06%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
52.44%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
52.44%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
52.44%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Share reduction more than 1.5x 2127.T's 1.31%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 2127.T's 1.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.55%
10Y revenue/share CAGR under 50% of 2127.T's 504.31%. Michael Burry would suspect a lasting competitive disadvantage.
59.61%
5Y revenue/share CAGR at 50-75% of 2127.T's 111.52%. Martin Whitman would worry about a lagging mid-term growth trajectory.
26.86%
3Y revenue/share CAGR at 50-75% of 2127.T's 46.29%. Martin Whitman would question if the firm lags behind competitor innovations.
100.00%
Positive long-term OCF/share growth while 2127.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
222.32%
Below 50% of 2127.T's 506.19%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
177.62%
5Y net income/share CAGR above 1.5x 2127.T's 97.43%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
107.89%
3Y net income/share CAGR above 1.5x 2127.T's 33.50%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
194.93%
Below 50% of 2127.T's 650.83%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
125.91%
5Y equity/share CAGR at 75-90% of 2127.T's 165.40%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
59.94%
3Y equity/share CAGR at 50-75% of 2127.T's 100.28%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 2127.T invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
10.26%
AR growth well above 2127.T's 18.18%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.27%
Inventory is declining while 2127.T stands at 26.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.24%
Asset growth above 1.5x 2127.T's 0.43%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.71%
BV/share growth above 1.5x 2127.T's 0.67%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.89%
We’re deleveraging while 2127.T stands at 5.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.94%
We cut SG&A while 2127.T invests at 23.95%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.